| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT07520162 A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP… |
Trial sites expanded: 21 -> 39 locations |
| 2026-08-15 | NCT06627647 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for… |
Trial sites expanded: 287 -> 295 locations |
| 2026-08-15 | NCT07457151 Danicopan PMS in Korea |
Enrollment increased: 8 -> 27 participants |
| 2026-08-14 | NCT06252753 Observational Study Protocol: LIVER-R |
Primary endpoint(s) modified |
| 2026-08-14 | NCT06252753 Observational Study Protocol: LIVER-R |
Enrollment reduced: 4490 -> 4000 participants |
| 2026-08-14 | NCT06252753 Observational Study Protocol: LIVER-R |
Trial arms changed: 2 -> 4 |
| 2026-08-14 | NCT07481526 A Prospecitve Multicenter, Observational Registry Study |
Primary endpoint(s) modified |
| 2026-08-14 | NCT07481526 A Prospecitve Multicenter, Observational Registry Study |
Trial sites expanded: 1 -> 59 locations |
| 2026-08-14 | NCT06795022 First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic… |
date change Primary completion moved earlier: 2028-02-25 -> 2027-06-30 |
| 2026-08-14 | NCT07593248 Real-World Outcomes of Resected EGFR-Mutated NSCLC Patients Treated With Adjuvant… |
Trial sites expanded: 1 -> 14 locations |
| 2026-08-14 | NCT07220954 A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations… |
Enrollment closed, study ongoing |
| 2026-08-14 | NCT07220954 A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations… |
date change Completion pushed: 2027-04-01 -> 2027-05-21 |
| 2026-08-14 | NCT06307665 Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in… |
Trial sites expanded: 144 -> 150 locations |
| 2026-08-14 | NCT06465485 STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With… |
Trial completed |
| 2026-08-14 | NCT06465485 STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With… |
Primary endpoint(s) modified |
| 2026-08-14 | NCT06526793 Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R)… |
date change Primary completion pushed: 2027-11-24 -> 2028-04-21 |
| 2026-08-14 | NCT06692738 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for… |
Trial sites expanded: 312 -> 325 locations |
| 2026-08-13 | NCT07520162 A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP… |
Trial sites reduced: 33 -> 21 locations |
| 2026-08-13 | NCT05417594 Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in… |
date change Primary completion pushed: 2027-11-01 -> 2028-02-07 |
| 2026-08-13 | NCT05417594 Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in… |
date change Completion pushed: 2027-11-01 -> 2028-02-07 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-14 | NCT07764978 Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT | Phase 3 | Recruiting |
| 2026-08-12 | NCT07760519 A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With… | Not Yet Recruiting | |
| 2026-08-12 | NCT07761117 A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult… | Phase 3 | Not Yet Recruiting |
| 2026-08-10 | NCT07753993 A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult… | Phase 3 | Not Yet Recruiting |
| 2026-08-10 | NCT07754331 Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of… | Phase 1 | Not Yet Recruiting |
| 2026-08-07 | NCT07751848 A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active… | Phase 3 | Not Yet Recruiting |
| 2026-08-04 | NCT07743944 A Real-world Study Observing Treatment Patterns and Clinical Results for Patients in… | Recruiting | |
| 2026-07-30 | NCT07735637 A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared… | Phase 3 | Not Yet Recruiting |
| 2026-07-28 | NCT07732361 A Study Using Real-world Data to Examine Outcomes in Children and Adults Who Develop a… | Completed | |
| 2026-07-23 | NCT07723833 A Study to Investigate the Relative Bioavailability and Safety of Different Oral… | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06429761 | Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients | BREAST CANCER | Recruiting |
| NCT07306949 | Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association… | Transthyretin-type Cardiac Amyloidosis | Recruiting |
| NCT07221838 | A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia… | Generalized Myasthenia Gravis | Recruiting |
| NCT07308574 | Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS | aHUS | Recruiting |
| NCT07279935 | Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After… | Non-small Cell Lung Cancer | Recruiting |
| NCT06594068 | Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in… | Systemic Lupus Erythematosus | Recruiting |
| NCT06531798 | Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian… | Moderate to Severe COPD | Recruiting |
| NCT07073950 | A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate… | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT07357597 | An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd)… | Stomatitis | Recruiting |
| NCT06651970 | Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL… | Chronic Lymphocytic Leukaemia | Recruiting |
| NCT06610526 | A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease | Chronic Kidney Disease | Active, Not Recruiting |
| NCT05457257 | Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With… | Metastatic Castration-resistant Prostate Cancer | Active, Not Recruiting |
| NCT06422689 | Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on… | Asthma | Active, Not Recruiting |
| NCT03953300 | Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics | Asthma | Active, Not Recruiting |
| Phase 3 | |||
| NCT06449001 | Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric… | Paroxysmal Nocturnal Hemoglobinuria | Recruiting |
| NCT06607627 | PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+… | Generalized Myasthenia Gravis | Recruiting |
| NCT06350097 | Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab… | Non-small Cell Lung Cancer | Recruiting |
| NCT06750289 | Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as… | Eosinophilic Asthma | Recruiting |
| NCT06417814 | A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib… | Metastatic Non-small Cell Lung Cancer | Recruiting |
| NCT06455449 | A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as… | Polymyositis, Dermatomyositis | Recruiting |
| NCT05211895 | A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent… | Non-Small Cell Lung Cancer | Recruiting |
| NCT06764875 | A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab… | HER2-positive Gastric Cancer | Recruiting |
| NCT06830798 | Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy… | Delayed Graft Function | Recruiting |
| NCT07215585 | AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL | Large B-cell Lymphoma | Recruiting |
| NCT06283966 | A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate… | COPD (Chronic Obstructive Pulmonary Disease) | Recruiting |